Evidence map›Paper›PMID 38125841›Full record

ArticleFrontiers in public health2023

"COAGULATION": a mnemonic device for treating coagulation disorders following traumatic brain injury-a narrative-based method in the intensive care unit.

Manuel Quintana-Diaz, Pasquale Anania, Raúl Juárez-Vela, Emmanuel Echaniz-Serrano, Clara Isabel Tejada-Garrido, Pilar Sanchez-Conde, Kapil Nanwani-Nanwani, Ainhoa Serrano-Lázaro, Pilar Marcos-Neira, María Gero-Escapa and 2 more

Open access · goldAbstract readComment
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 3 countries.

Manuel Quintana-DiazDepartment of Medicine, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain.
Pasquale AnaniaDepartment of Neurosurgery, Ospedale Policlinico San Martino, Istituto di Ricovero eCura a Carattere Scientifico (IRCCS) for Oncology and Neuroscience, Genoa, Italy.
Raúl Juárez-VelaInstitute for Health Research (idiPAZ), La Paz University Hospital, Madrid, Spain.
Emmanuel Echaniz-SerranoDepartment of Nursing and Physiatry, Faculty of Health Sciences, University of Zaragoza, Zaragoza, Spain.
Clara Isabel Tejada-GarridoDepartment of Nursing, University of La Rioja, Logroño, Spain.
Pilar Sanchez-CondeFaculty of Medicine, University of Salamanca, Salamanca, Spain.
Kapil Nanwani-NanwaniIntensive Care Unit, La Paz University Hospital, Madrid, Spain.
Ainhoa Serrano-LázaroInstitute for Health Research (idiPAZ), La Paz University Hospital, Madrid, Spain.
Pilar Marcos-NeiraIntensive Care Unit, Germans Trias i Pujol University Hospital, Badalona, Spain.
María Gero-EscapaIntensive Care Unit, Burgos University Hospital, Burgos, Spain.
Jorge García-CriadoEmergency Department, University Hospital of Salamanca, Salamanca, Spain.
Daniel Agustín GodoyCritical Care Department, Neurointensive Care Unit, Sanatorio Pasteur, Catamarca, Argentina.
Hospital La Paz Institute for Health Research · ESUniversidad de La Rioja · ESUniversidad de Salamanca · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitario La Paz · ESNational University of Catamarca · AROspedale Policlinico San Martino · ITServicio Aragonés de Salud · ESUniversidad de Burgos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Coagulopathy associated with isolated traumatic brain injury (C-iTBI) is a frequent complication associated with poor outcomes, primarily due to its role in the development or progression of haemorrhagic brain lesions. The independent risk factors for its onset are age, severity of traumatic brain injury (TBI), volume of fluids administered during resuscitation, and pre-injury use of antithrombotic drugs. Although the pathophysiology of C-iTBI has not been fully elucidated, two distinct stages have been identified: an initial hypocoagulable phase that begins within the first 24 h, dominated by platelet dysfunction and hyperfibrinolysis, followed by a hypercoagulable state that generally starts 72 h after the trauma. The aim of this study was to design an acronym as a mnemonic device to provide clinicians with an auxiliary tool in the treatment of this complication. Methods: A narrative analysis was performed in which intensive care physicians were asked to list the key factors related to C-iTBI. The initial sample was comprised of 33 respondents. Respondents who were not physicians, not currently working in or with experience in coagulopathy were excluded. Interviews were conducted for a month until the sample was saturated. Each participant was asked a single question: Can you identify a factor associated with coagulopathy in patients with TBI? Factors identified by respondents were then submitted to a quality check based on published studies and proven evidence. Because all the factors identified had strong support in the literature, none was eliminated. An acronym was then developed to create the mnemonic device. Results and conclusion: Eleven factors were identified: cerebral computed tomography, oral anticoagulant & antiplatelet use, arterial blood pressure (Hypotension), goal-directed haemostatic therapy, use fluids cautiously, low calcium levels, anaemia-transfusion, temperature, international normalised ratio (INR), oral antithrombotic reversal, normal acid-base status, forming the acronym "Coagulation." This acronym is a simple mnemonic device, easy to apply for anyone facing the challenge of treating patients of moderate or severe TBI on a daily basis.

Indexed as

Blood Coagulation DisordersBrain Injuries, TraumaticAnticoagulantsBlood CoagulationFibrinolytic AgentsHumansIntensive Care UnitsAnticoagulantsFibrinolytic Agentsanticoagulantsantithrombotic drugsblood coagulationcoagulopathydiagnosishaemostasistraumatic brain injury

Identifiers

PMID38125841
PMCPMC10730733
OpenAlexW4389393409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.